COHN JAY N MD 4

4 · HYPERTENSION DIAGNOSTICS INC /MN · Filed Aug 10, 2004

Form 4

Period: 2004-08-06

Director

Transactions

Conversion
Common Stock Warrant (right to buy)
2004-08-06$0.17/sh−305,338$51,907→ 305,338 total
Exercise: $0.17Exp: 2004-11-09→ Common Stock (610,676 underlying)
Conversion
Series A Preferred Stock Warrant (right to buy)
2004-08-06$2.04/sh−19,200$39,168→ 19,200 total
Exercise: $2.04Exp: 2004-11-09→ Series A Preferred Stock (38,400 underlying)
Conversion
Common Stock
2004-08-06$0.17/sh+305,338$51,907→ 305,338 total
Conversion
Series A Preferred Stock
2004-08-06$2.04/sh+19,200$39,168→ 19,200 total
Exercise: $2.04→ Series A Preferred Stock (19,200 underlying)

Holdings

Common Stock
(indirect: By Spouse)
12,500
Series A Preferred Stock
→ Common Stock (38,400 underlying)
460,800
Options (right to buy)
→ Common Stock (100,000 underlying)
100,000
Series A Preferred Stock Warrant (right to buy)
→ Series A Preferred Stock (30,720 underlying)
30,720
Options (right to buy)
→ Common Stock (352,211 underlying)
352,211
Options (right to buy)
→ Common Stock (5,000 underlying)
5,000
Options (right to buy)
→ Common Stock (3,000 underlying)
3,000
Common Stock Warrant (right to buy)
→ Common Stock (488,542 underlying)
488,542
Common Stock Warrant (right to buy)
→ Common Stock (427,474 underlying)
427,474
Common Stock
702,350
Series A Preferred Stock Warrant (right to buy)
→ Series A Preferred Stock (26,880 underlying)
26,880
Options (right to buy)
→ Common Stock (300,000 underlying)
300,000

Footnotes (5)

[F1]Previously reported.
[F2]See Table I.
[F3]The purchase represents reporting person's exercise of the issuer's A-1 Preferred Stock Warrant and A-2 Common Stock Warrant.
[F4]Expiration date extended to November 9, 2004; shares issued on August 6, 2004.
[F5]Not applicable.

Documents

1 file